Brian Kotzin

Brian L.
Kotzin is currently Director at Benaroya Research Institute at Virginia Mason, Independent Director at Biora Therapeutics, Inc. since 2019, Non-Executive Director at argenx SE since 2024, Director at Genascence Corp.
since 2022, and Member of the Association of American Physicians and the American Society of Clinical Investigation.
Former positions include Chairman of the Immunological Sciences Study Section at the National Institutes of Health, Director at the American College of Rheumatology, Federation of Clinical Immunology Societies, and Vera Therapeutics, Inc., Director and Head of Clinical Immunology at the Autoimmunity Center of Excellence from 1998 to 2004, Director of the Autoimmunity Centre of Excellence at the University of Colorado Health Sciences Center from 1981 to 2004, Independent Director at Kyverna Therapeutics, Inc. from 2019 to 2024, Independent Director at Rigel Pharmaceuticals, Inc. from 2017 to 2024, Vice President of Global Clinical Development and Head of Inflammation at Amgen, Inc. from 2004 to 2015, Chief of the Rheumatology Section at Veterans Administration Medical Center, Professor at National Jewish Health, Inc., and Chief Medical Officer at Nektar Therapeutics in 2023.
Education includes undergraduate studies at the University of Southern California and a doctorate from Stanford University School of Medicine.